Ophthalmology
Volume 112, Issue 3 , Pages 460-465, March 2005

Interim results of the United States investigational device study of the Ophtec capsular tension ring

Presented at: American Academy of Ophthalomology Annual Meeting, November, 2003; Anaheim, California.

  • Francis W. Price Jr, MD

      Affiliations

    • Price Vision Group, Indianapolis, Indiana
    • Corresponding Author InformationCorrespondence to Francis W. Price, Jr, MD, Price Vision Group, 9002 North Meridian Street, Suite 100, Indianapolis, IN 46260
  • ,
  • Richard J. Mackool, MD

      Affiliations

    • Mackool Eye Institute, Queens, New York
  • ,
  • Kevin M. Miller, MD

      Affiliations

    • Jules Stein Eye Institute, Los Angeles, California
  • ,
  • Paul Koch, MD

      Affiliations

    • Koch Eye Associates, Warwick, Rhode Island
  • ,
  • Thomas A. Oetting, MD

      Affiliations

    • University of Iowa Hospitals and Clinics, Iowa City, Iowa
  • ,
  • A. Tim Johnson, MD, PhD

      Affiliations

    • University of Iowa Hospitals and Clinics, Iowa City, Iowa

Received 1 December 2003; accepted 14 September 2004. published online 29 December 2004.

Purpose

To evaluate the safety and efficacy of the Ophtec capsular tension ring (CTR) in providing capsular support during and/or after cataract extraction in cases of a weak or partially broken ciliary zonule.

Design

Phase III multicenter, nonrandomized, investigational device study.

Participants

Twelve investigators at 9 sites enrolled 224 subjects and placed 255 CTRs.

Methods

Capsular tension rings were placed in patients who were found to have a weakened or partially broken ciliary zonule comprising <34% of the circumference of the lens capsule. Two CTR models were evaluated, with noncompressed diameters of 12 mm and 13 mm. Patients were examined preoperatively, intraoperatively, and postoperatively at day 1 and months 1, 3, 6, and 12.

Main outcome measures

Rate of successful stabilization of the capsular bag and intraocular lens (IOL) centration, complications, and adverse events.

Results

Interim results from this ongoing study indicate that immediately after surgery 98.8% of IOLs were centered and 1.2% of the IOLs implanted (3/251) were not centered. Subsequently, the prevalence of decentered IOLs was 1.7% (4/236) 3 months after surgery, 3.8% (8/211) 6 months after surgery, and 2.3% (4/172) 12 months after surgery. The primary complication was posterior capsular opacification, which is unlikely to be a complication of CTR insertion. Neodymium:yttrium–aluminum–garnet laser capsulotomies have been performed in 12.8% of eyes by 12 months (22/172).

Conclusions

Ophtec CTR models 275 and 276 safely provided capsular support during and after cataract surgery in cases where the zonule was weak or partially broken.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Manuscript no. 230824.

 The authors have no financial interests related to this article or devices mentioned therein.

 The study was sponsored by Ophtec, USA, Boca Raton, Florida.

PII: S0161-6420(04)01494-0

doi:10.1016/j.ophtha.2004.09.022

Ophthalmology
Volume 112, Issue 3 , Pages 460-465, March 2005